DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference Call
March 18 2019 - 12:56PM
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its
2018 financial results will be released after market close on
Tuesday, March 19th. DiaMedica’s management will host a live
conference call on Wednesday, March 20th at 8:00am Central Time to
provide a business update and discuss the Company’s financial
results.
Conference Call details:
Date: |
March
20, 2019 |
Time: |
8:00 AM
CT |
Web
access: |
https://edge.media-server.com/m6/p/idbwv4bq |
Dial
In: |
(866)
962-3593 (domestic) |
|
(630)
652-5857 (international) |
Conference ID: |
6773627 |
Listeners should log on to the website or dial in
15 minutes prior to the call. The webcast will remain
available for play back on our website, under investor events and
presentations, following the earnings call and for 12 months
thereafter. A telephonic replay of the conference call will be
available until March 28, 2019, by dialing 1(855) 859-2056 (US Toll
Free Dial In), (404) 537-3406 (international), replay passcode
6773627.
About DiaMedica Therapeutics
Inc.
DiaMedica Therapeutics Inc. is a clinical stage
biopharmaceutical company focused on developing novel treatments
for chronic kidney diseases and neurological disorders. The Company
currently has an ongoing phase II study in acute ischemic stroke
and a phase Ib study in chronic kidney disease. DiaMedica’s shares
are listed on The Nasdaq Capital Market under the trading symbol
“DMAC.”
For more information, please visit
www.diamedica.com.
Contact:
Scott KellenChief Financial OfficerPhone: (763)
496-5118 skellen@diamedica.com
Paul Papi Vice President of Business Development
Phone: (617) 899-5941info@diamedica.com
DiaMedica Inc. (TSXV:DMA)
Historical Stock Chart
From Jul 2024 to Aug 2024
DiaMedica Inc. (TSXV:DMA)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Diamedica Therapeutics (TSX Venture Exchange): 0 recent articles
More News Articles